Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidoneMARTIN, Stephen D; LIBRETTO, Susan E; PRATT, David J et al.Current medical research and opinion. 2003, Vol 19, Num 4, pp 298-305, issn 0300-7995, 8 p.Article

Role of ethnicity in predicting antipsychotic medication adherenceOPOLKA, Jayme L; RASCATI, Karen L; BROWN, Carolyn M et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 625-630, issn 1060-0280, 6 p.Article

Antipsychotic polypharmacy: a needle in a haystack?DE TORRE, Amaia López; LERTXUNDI, Unax; HERNANDEZ, Rafael et al.General hospital psychiatry. 2012, Vol 34, Num 4, pp 423-432, issn 0163-8343, 10 p.Article

Atypical antipsychotics in mood disordersKASPER, Siegfried; STAMENKOVIC, Mara; LETMAIER, Martin et al.International clinical psychopharmacology. 2002, Vol 17, pp S1-S10, issn 0268-1315, SUP3Conference Paper

Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivativesSANCHEZ-MATEO, Candelaria C; DARIAS, Victoriano; ALBERTOS, Luz M et al.Arzneimittel-Forschung. 2003, Vol 53, Num 1, pp 12-20, issn 0004-4172, 9 p.Article

Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)_2A antagonist, MDL100,907DEKEYNE, A; IOB, L; MILLAN, M. J et al.Neuropharmacology. 2003, Vol 44, Num 5, pp 604-615, issn 0028-3908, 12 p.Article

Decreased serum neurotrophin 3 in chronically medicated schizophrenic mâlesEVANGELISTA VARGAS, Haroldo; SEVERINO GAMA, Clarissa; BELMONTE-DE-ABREU, Paulo Silva et al.Neuroscience letters. 2008, Vol 440, Num 3, pp 197-201, issn 0304-3940, 5 p.Article

A Qualitative Study of Experiences With and Perceptions Regarding Long-Acting Injectable Antipsychotics: Part II—Physician PerspectivesIYER, Srividya; BANKS, Nicola; ROY, Marc-André et al.Canadian journal of psychiatry. 2013, Vol 58, Num 5, issn 0706-7437, 23-S29S, SUP1Article

Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort studyLAUNDON, Walter; MUZYK, Andrew J; GAGLIARDI, Jane P et al.General hospital psychiatry. 2012, Vol 34, Num 4, pp 380-384, issn 0163-8343, 5 p.Article

Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrainSEILLIER, A; COUTUREAU, E; THIRIET, N et al.Neuropharmacology. 2003, Vol 45, Num 2, pp 190-200, issn 0028-3908, 11 p.Article

Delusional infestation: Neural correlates and antipsychotic therapy investigated by multimodal neuroimagingFREUDENMANN, Roland W; KÖLLE, Markus; HUWE, Axel et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 7, pp 1215-1222, issn 0278-5846, 8 p.Article

Weight effects associated with antipsychotics: A comprehensive database analysisPARSONS, Bruce; ALLISON, David B; LOEBEL, Antony et al.Schizophrenia research. 2009, Vol 110, Num 1-3, pp 103-110, issn 0920-9964, 8 p.Article

Reversal of antipsychotic-induced weight gain during quetiapine treatmentKOPONEN, Hannu; LARMO, Ilkka.International clinical psychopharmacology. 2003, Vol 18, Num 6, pp 355-356, issn 0268-1315, 2 p.Article

Two clusters of serum midkine levels in drug-naive patients with schizophreniaSHIMIZU, Eiji; HASHIMOTO, Kenji; OKADA, Sinichi et al.Neuroscience letters. 2003, Vol 344, Num 2, pp 95-98, issn 0304-3940, 4 p.Article

The use of electronic monitoring (MEMS®) to evaluate antipsychotic compliance in outpatients with schizophreniaREMINGTON, Gary; KWON, Jean; COLLINS, April et al.Schizophrenia research. 2007, Vol 90, Num 1-3, pp 229-237, issn 0920-9964, 9 p.Article

Effects of second generation antipsychotics on leptin and ghrelinESEN-DANACI, Avsen; SARANDÖL, Asli; TANELI, Fatma et al.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 6, pp 1434-1438, issn 0278-5846, 5 p.Article

Erythrocyte choline transport in drug-free and lithium-treated individualsMALLINGER, A. G; KOPP, U; HANIN, I et al.Journal of psychiatric research. 1984, Vol 18, Num 2, pp 107-117, issn 0022-3956Article

Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatmentWALLER, D. G; ALBANO, J. D. M; MILLAR, J. G. B et al.Clinical science (1979). 1984, Vol 66, Num 5, pp 557-559, issn 0143-5221Article

Antipsychotic drugs and diabetes- : an application of the Austin Bradford Hill criteriaHOLT, R. I. G; PEVELER, R. C.Diabetologia (Berlin). 2006, Vol 49, Num 7, pp 1467-1476, issn 0012-186X, 10 p.Article

Lithium concentration in the muscle compartment of manic-depressive patients during lithium therapyEHRLICH, B. E; CLAUSEN, C; GOSENFELD, L. F et al.Journal of psychiatric research. 1984, Vol 18, Num 2, pp 139-148, issn 0022-3956Article

Determinants of antipsychotic polypharmacy in psychiatric inpatients : a prospective studyBIANCOSINO, Bruno; BARBUI, Corrado; MARMAI, Luciana et al.International clinical psychopharmacology. 2005, Vol 20, Num 6, pp 305-309, issn 0268-1315, 5 p.Article

Therapeutic Drug Monitoring of Common AntipsychoticsPATTEET, Lisbeth; MORRENS, Manuel; MAUDENS, Kristof E et al.Therapeutic drug monitoring. 2012, Vol 34, Num 6, pp 629-651, issn 0163-4356, 23 p.Article

Sexual dysfunction in patients with schizophrenia on antipsychotic medicationUCOK, Alp; INCESU, Cem; AKER, Tamer et al.European psychiatry. 2007, Vol 22, Num 5, pp 328-333, issn 0924-9338, 6 p.Article

Antipsychotic medication and cognitive function in schizophreniaHORI, Hiroaki; NOGUCHI, Hiroko; SAITOH, Osamu et al.Schizophrenia research. 2006, Vol 86, Num 1-3, pp 138-146, issn 0920-9964, 9 p.Article

Obesity in schizophrenic outpatients receiving antipsychotics in TaiwanHSIAO, Cheng-Cheng; REE, Shao-Chun; CHIANG, Yuan-Lin et al.Psychiatry and clinical neurosciences (Carlton. Print). 2004, Vol 58, Num 4, pp 403-409, issn 1323-1316, 7 p.Article